…2-positive breast cancer who have received prior treatment with trastuzumab emtansine, or at least one prior anti-HER2-based regimen in the metastati…
T-Dxd
This drug is selected. Its supporting articles are shown below.
Articles mentioning T-Dxd
6 articles · page 1 of 1…Background and Importance Trastuzumab deruxtecan (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-pos…
…BL/6-hNectin4, or WT mice. Tumor-bearing mice received T-Dxd or enfortumab vedotin monotherapy, or combination therapy with anti-PD1.Results The l…
…of interest in 30 GCs—these contained 15 HER2+ GCs treated with trastuzumab and T-DXd subsequently. Analysis of patient-matched samples wit…
…erapy will be included and randomised 1:1 to receive either (1) docetaxel (or paclitaxel), carboplatin, trastuzumab (H) and pertuzumab (P…
…ody-drug conjugates, such as trastuzumab deruxtecan (T-DXd) and disitamab vedotin (RC48), has been pivotal in rendering ‘HER-2-low’ gastric cance…